News
The award budget for the 2022 SBIR/STTR grants solicitation has been revised: Total funding support (direct costs, indirect costs, fee) normally may not exceed $295,924 for Phase I awards and $1,972,828 for Phase II awards. For specific topics, NIH may exceed these total award amounts. Explore the list of approved topics.
Learn more about the revised award budget in the Guide Notice (NOT-OD-23-016).
Are you interested in SBIR or STTR funding to help propel your life science technology toward commercialization? The Applicant Assistance Program (AAP) can provide you with expert guidance on the NIH small business application process. Learn more and apply by Monday, December 12, at 5:00 p.m. ET.
Participating Institutes and Centers:
The FDA recently announced an opportunity for a limited number of applicants to participate in a Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) program, to facilitate the expedited CMC development of products under an investigational new drug (IND) application, where warranted, based upon the anticipated clinical benefit of earlier patient access to the products.
Applications will be accepted beginning Saturday, April 1, 2023.
Learn more about this pilot program.
|
